These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 10654630)

  • 1. Can we prevent antimicrobial resistance by using antimicrobials better?
    Soothill G; Hu Y; Coates A
    Pathogens; 2013 Jun; 2(2):422-35. PubMed ID: 25437042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring susceptibility to aminoglycosides: identifying small molecule inhibitors of enzymatic inactivation.
    Magaña AJ; Sklenicka J; Pinilla C; Giulianotti M; Chapagain P; Santos R; Ramirez MS; Tolmasky ME
    RSC Med Chem; 2023 Sep; 14(9):1591-1602. PubMed ID: 37731693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro.
    Yoshida M; Reyes SG; Tsuda S; Horinouchi T; Furusawa C; Cronin L
    Nat Commun; 2017 Jun; 8():15589. PubMed ID: 28593940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial.
    van Duijn PJ; Bonten MJ
    Trials; 2014 Jul; 15():277. PubMed ID: 25011604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center.
    Borde JP; Kaier K; Steib-Bauert M; Vach W; Geibel-Zehender A; Busch H; Bertz H; Hug M; de With K; Kern WV
    BMC Infect Dis; 2014 Apr; 14():201. PubMed ID: 24731220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.
    Francetić I; Kalenić S; Huić M; Mercep I; Makar-Ausperger K; Likić R; Erdeljić V; Tripković V; Simić P
    Croat Med J; 2008 Apr; 49(2):207-14. PubMed ID: 18461676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?
    Ehlenbach WJ; Curtis JR
    Crit Care Med; 2008 Mar; 36(3):1003-4. PubMed ID: 18431302
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial stewardship programs in health care systems.
    MacDougall C; Polk RE
    Clin Microbiol Rev; 2005 Oct; 18(4):638-56. PubMed ID: 16223951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an antibiotic cycling program on antibiotic prescribing practices in an intensive care unit.
    Merz LR; Warren DK; Kollef MH; Fraser VJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2861-5. PubMed ID: 15273092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions.
    Walker ES; Levy F; Shorman M; David G; Abdalla J; Sarubbi FA
    J Clin Microbiol; 2004 Jun; 42(6):2792-5. PubMed ID: 15184473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics.
    Weinstein RA
    Emerg Infect Dis; 2001; 7(2):188-92. PubMed ID: 11294703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy reviews: Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics--part 4: aminoglycosides.
    Barza M; Scheife RT
    Am J Hosp Pharm; 1977 Jul; 34(7):723-37. PubMed ID: 407790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of curbing aminoglycoside resistance: can antimicrobial stewardship programs play a critical role?
    Pitiriga V; Dimitroulia E; Saroglou G; Tsakris A
    Expert Rev Anti Infect Ther; 2017 Oct; 15(10):947-954. PubMed ID: 28929815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials].
    Corso A; Galas MF; Rossi MA
    Rev Argent Microbiol; 1996; 28(3):123-31. PubMed ID: 9026822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial cycling: lessons learned from the aminoglycoside experience.
    Gerding DN
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S12-7. PubMed ID: 10654630
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.